Nucleoside radiosensitizers

DS Shewach, TS Lawrence - Deoxynucleoside analogs in cancer therapy, 2006 - Springer
Nucleoside/nucleobase analogs (bromodeoxyuridine, iododeoxyuridine, 5fluorouracil,
fluorodeoxyuridine, difluorodeoxycytidine, fluoroadenine arabinoside …

Radiosensitizing nucleosides

CJ McGinn, DS Shewach… - JNCI: Journal of the …, 1996 - academic.oup.com
Chemotherapeutic drugs that perturb nucleotide metabolism have the potential to produce
substantial sensitization of tumor cells to radiation treatment. The process is called …

Chemo-radiotherapy: radiosensitizing nucleoside analogues

V Grégoire, WN Hittelman, JF Rosier… - Oncology …, 1999 - spandidos-publications.com
The available knowledge on potential radiosensitizing nucleoside analogues with special
focus on fludarabine and gemcitabine is reviewed. These analogues are prodrugs whose …

Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells

CE Bruso, DS Shewach, TS Lawrence - International Journal of Radiation …, 1990 - Elsevier
The halogenated pyrimidine, fluorodeoxyuridine (FdUrd), has been used in combination
with radiation for the treatment of human neoplasms. In an attempt to improve the clinical …

The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization

TS Lawrence, DK Heimburger, DS Shewach - International Journal of …, 1991 - Elsevier
The biomodulators leucovorin and dipyridamole potentiate the cytotoxicity of 5-
fluorodeoxyuridine (FdUrd) and 5-fluorouracil (5-FU), respectively. It was hypothesized that …

Nucleoside analogs as radiosensitizing agents

V Grégoire, WN Hittelman - Nucleoside analogs in cancer therapy, 2021 - taylorfrancis.com
This chapter outlines the available knowledge on radiosensitization by arabinosylpurine and
arabinosylpyrimidine nucleoside analogs. A variety of experimental studies have …

Antimetabolite radiosensitizers

DS Shewach, TS Lawrence - Journal of Clinical Oncology, 2007 - ascopubs.org
Radiosensitization with antimetabolites has improved clinical outcome for patients with solid
malignancies, especially cancers of the GI tract, cervix, and head and neck. Fluorouracil …

Recent advances in the use of radiosensitizing nucleosides

CJ McGinn, TS Lawrence - Seminars in radiation oncology, 2001 - Elsevier
Chemotherapeutic drugs that perturb nucleotide metabolism have the potential to produce
substantial sensitization of tumor cells to radiation treament. The clinical effectiveness of …

The Ribonucleoside Diphosphate Reductase Inhibitor (E)-2′-Deoxy-(fluoromethylene)cytidine as a Cytotoxic Radiosensitizer in Vitro

PA Coucke, LA Decosterd, YX Li, E Cottin, X Chen… - Cancer research, 1999 - AACR
Abstract (E)-2′-Deoxy-(fluoromethylene) cytidine (FMdC) is known as an inhibitor of
ribonucleoside diphosphate reductase, a key enzyme in the de novo pathway of DNA …

Biochemical pharmacology of chemotherapeutic drugs used as radiation enhancers.

RL Schilsky - Seminars in oncology, 1992 - europepmc.org
Radiotherapy and chemotherapy are often administered concurrently in an attempt to take
advantage of postulated biochemical or molecular interactions between the two modalities. It …